Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Octave Bioscience Inc.

www.octavebio.com

Latest From Octave Bioscience Inc.

Finance Watch: Landos Raises $60m Series B Round Ahead Of Phase II Data In 2020

If Landos goes public late next year, its financing strategy will align with venture capital and IPO trends observed in a new Jefferies report. Also, D&D Pharmatech raises $137.1m in VC cash, Sonnet secures up to $100m and the CF Foundation commits up to $15m to Arcturus.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Digital Health
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Octave Bioscience Inc.
  • Senior Management
  • Contact Info
  • Octave Bioscience Inc.
    1455 Adams Dr.
    Ste. 1006
    Menlo Park, 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register